- India has become a signatory to TRIPS.
- Commencing 2005, there have been drastic changes in patent laws and its applications within India.
- To introduce new drugs in India, clinical trials are mandatory.
- Clinical trials are required to be conducted as per ICH-GCP norms.
- There is a huge demand for qualified and trained Clinical Research Professionals (See chart below).
Resources |
2002 (Center Watch) |
2010 (Center Watch) |
2010 (Mckinsey) |
CR Market |
US $ 30 - 35 Million |
US $ 250 - 300 Million |
US $ 1.5 Billion |
GCP Studies |
40 - 50 Million |
250-300 Million |
1,500-2,000 Million |
GCP Trained Investigators |
200 - 250 |
2500 - 3000 |
10,000 - 15,000 Investigators |
Subjects Required |
4,000-5,000 |
50,000 - 60,000 |
2,00,000 - 3,00,000 |
CR Professionals |
120 - 150 |
1,500 - 1,800 |
6,000-9,000 |
Internationally, the demand for clinical research specialists is even stronger than in India. The shortage globally traverses all continents including most notably North America, Europe, as well as Asia. While most EU, Canadian, and US employers are outsourcing the majority of the clinical research work to India, there are jobs available to Mir-IFCR grads in the US and EU and Mir-IFCR graduates meet US and Canadian immigration requirements.
These same employers from the US, EU and Canada, though, have thousands of jobs available across India, which has become one of the world's leading centers for clinical research.
No comments:
Post a Comment